CAT and breast cancer: A type of composite nanoparticles loaded with epirubicin and CUR within an SLN system loaded for treating recurrent BC showed good blood and immune compatibility and did not affect intracellular superoxide dismutase (SOD) and intracellular catalase (CAT) [104].